AbCellera Biologics (ABCL) FCF Margin (2020 - 2026)
AbCellera Biologics (ABCL) posted FCF Margin of 449.24% for Q1 2026, down 351.93% on a QoQ basis from 99.4% in Q4 2025, and up 7473.0% year-over-year from 5.93% in Q1 2025.
AbCellera Biologics (ABCL) FCF Margin (2020 - 2026) Analysis & Trends
AbCellera Biologics' FCF Margin history runs 7 years deep, the most recent figure standing at 449.24% for Q1 2026.
- Quarterly FCF Margin rose 7473.0% year-over-year to 449.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 238.91% (up 38101.0% YoY) and the FY2025 annual result came in at 231.69%, up 41670.0% from the prior year.
- FCF Margin was 449.24% for Q1 2026 at AbCellera Biologics, down from 99.4% in the prior quarter.
- Across five years, FCF Margin topped out at 526.37% in Q2 2022 and bottomed at 728.42% in Q3 2024.
- A 5-year average of 312.02% and a median of 370.87% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin sank 61124 bps — and 2025, when it jumped 41591 bps.
- AbCellera Biologics' FCF Margin stood at 86.25% in 2022, then sank by 530 bps to 370.87% in 2023, then declined by 26 bps to 467.92% in 2024, then jumped by 79 bps to 99.4% in 2025, then plunged by 352 bps to 449.24% in 2026.
- Business Quant data shows ABCL's FCF Margin at 449.24% in Q1 2026, 99.4% in Q4 2025, and 687.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | AbCellera Biologics | 1.62 Bn | 1.62 Bn | - | -449.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -449.24% |
| Dec 31, 2025 | -99.40% |
| Sep 30, 2025 | -687.01% |
| Jun 30, 2025 | -267.91% |
| Mar 31, 2025 | -523.97% |
| Dec 31, 2024 | -467.92% |
| Sep 30, 2024 | -728.42% |
| Jun 30, 2024 | -683.82% |
| Mar 31, 2024 | -661.52% |
| Dec 31, 2023 | -370.87% |
| Sep 30, 2023 | -309.70% |
| Jun 30, 2023 | -72.57% |
| Mar 31, 2023 | -484.31% |
| Dec 31, 2022 | 86.25% |
| Sep 30, 2022 | -137.40% |
| Jun 30, 2022 | 526.37% |
| Mar 31, 2022 | 27.08% |
| Dec 31, 2021 | -18.76% |
| Sep 30, 2021 | -263.36% |
| Jun 30, 2021 | 437.29% |